Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-19

Clinical Trial Update: Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sodium bicarbonate to prevent contrast-induced nephropathy in patients with renal impairment has completed, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Hospital Sao Lucas da PUCRS | Conditions: Renal Failure | Phase 3 | Status: COMPLETED | Results posted: 2014-02-19